Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Emanuele M. Gargano"'
Autor:
Rolf W. Hartmann, Chris J. van Koppen, Matthias W. Laschke, Giuseppe Felice Mangiatordi, Ahmed S. Abdelsamie, Martin Frotscher, Orazio Nicolotti, Abdelrahman Mohamed, Angelo Carotti, Arcangela Mazzini, Hanna Drzewiecka, Emanuele M. Gargano, Paweł P. Jagodziński, Sandrine Marchais-Oberwinkler
Publikováno v:
ACS medicinal chemistry letters
United States
ACS Med Chem Lett
ACS medicinal chemistry letters (2021). doi:10.1021/acsmedchemlett.1c00462
info:cnr-pdr/source/autori:Emanuele M. Gargano, Abdelrahman Mohamed, Ahmed S. Abdelsamie, Giuseppe F. Mangiatordi, Hanna Drzewiecka, Pawe? P. Jagodzi?ski, Arcangela Mazzini, Chris J. van Koppen, Matthias W. Laschke, Orazio Nicolotti, Angelo Carotti, Sandrine Marchais-Oberwinkler, Rolf W. Hartmann, and Martin Frotscher/titolo:17?-Hydroxysteroid Dehydrogenase Type 1 Inhibition: A Potential Treatment Option for Non-Small Cell Lung Cancer/doi:10.1021%2Facsmedchemlett.1c00462/rivista:ACS medicinal chemistry letters/anno:2021/pagina_da:/pagina_a:/intervallo_pagine:/volume
United States
ACS Med Chem Lett
ACS medicinal chemistry letters (2021). doi:10.1021/acsmedchemlett.1c00462
info:cnr-pdr/source/autori:Emanuele M. Gargano, Abdelrahman Mohamed, Ahmed S. Abdelsamie, Giuseppe F. Mangiatordi, Hanna Drzewiecka, Pawe? P. Jagodzi?ski, Arcangela Mazzini, Chris J. van Koppen, Matthias W. Laschke, Orazio Nicolotti, Angelo Carotti, Sandrine Marchais-Oberwinkler, Rolf W. Hartmann, and Martin Frotscher/titolo:17?-Hydroxysteroid Dehydrogenase Type 1 Inhibition: A Potential Treatment Option for Non-Small Cell Lung Cancer/doi:10.1021%2Facsmedchemlett.1c00462/rivista:ACS medicinal chemistry letters/anno:2021/pagina_da:/pagina_a:/intervallo_pagine:/volume
[Image: see text] In the face of the clinical challenge posed by non-small cell lung cancer (NSCLC), the present need for new therapeutic approaches is genuine. Up to now, no proof existed that 17β-hydroxysteroid dehydrogenase type 1 (17β-HSD1) is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b72b1eb9a0d3948ea61df325c6e341e
https://hdl.handle.net/10033/623149
https://hdl.handle.net/10033/623149
Autor:
Emanuele M Gargano, Giuseppe Allegretta, Enrico Perspicace, Angelo Carotti, Chris Van Koppen, Martin Frotscher, Sandrine Marchais-Oberwinkler, Rolf W Hartmann
Publikováno v:
PLoS ONE, Vol 10, Iss 7, p e0134754 (2015)
Design and synthesis of a new class of inhibitors for the treatment of osteoporosis and its comparative h17β-HSD2 and m17β-HSD2 SAR study are described. 17a is the first compound to show strong inhibition of both h17β-HSD2 and m17β-HSD2, intracel
Externí odkaz:
https://doaj.org/article/0bc4d2b54c854517a63ff00bf9fcb5c9
Autor:
Emanuele M. Gargano, Giuseppe Felice Mangiatordi, Carsten Goebel, Domenico Alberga, Stefan Wierlacher, Wolfgang Ruess, Orazio Nicolotti, Ingo Weber
Publikováno v:
ChemistryOpen
The stability and unconventional reactivity of 1,13‐diamino‐4,7,10‐trioxatridecane in the presence of NH3, H2O2, and (NH4)2S2O8 are described. The ether‐diamine is an ingredient marketed to hair salons and consumers for so‐called “plex”
Autor:
Daniel Neumann, Emanuele M. Gargano, Kimberly Zupko, Valerie Politano, Helga Rothe, Kirstin Kosemund-Meynen, Carsten Goebel, Sheppard Martin, Neelam Jaiswal, Jin Zhang, Gábor von Bölcshazy
Publikováno v:
Current Opinion in Toxicology. 5:46-54
A key part of the safety assessment for cosmetic ingredients is the evaluation of skin sensitization, i.e. their potency to induce an immune response in the skin involving the innate and the adaptive immune system. For decades the murine local lymph
Autor:
Martin Frotscher, Ahmed S. Abdelsamie, Emanuele M. Gargano, Martin Empting, Emmanuel Bey, Chris J. van Koppen
Publikováno v:
European Journal of Medicinal Chemistry. 103:56-68
17β-Estradiol (E2), the most potent human estrogen, is known to be involved in the etiology of estrogen-dependent diseases (EDD) like breast cancer and endometriosis. 17β-Hydroxysteroid dehydrogenase type 1 (17β-HSD1) catalyses the last step of E2
Autor:
Stefan Hinsberger, Rolf W. Hartmann, Emanuele M. Gargano, Marie Wetzel, Sandrine Marchais-Oberwinkler
Publikováno v:
European Journal of Medicinal Chemistry. 47:1-17
E2 deficiency in elderly people has directly an effect on the skeleton and can lead to osteoporosis. As 17β-hydroxysteroid dehydrogenase type 2 (17β-HSD2) catalyses the conversion between active 17β-hydroxysteroid estradiol (E2) and testosterone (
Autor:
Emanuele M. Gargano, Giuseppe Felice Mangiatordi, Ingo Weber, Wolfgang Ruess, Orazio Nicolotti, Stefan Wierlacher, Carsten Goebel, Domenico Alberga
Publikováno v:
ChemistryOpen
The Cover Feature shows a persulfate reaction occurring under the conditions of a cosmetic hair bleaching procedure, applied worldwide to lighten hair. 1,13‐diamino‐4,7,10‐trioxatridecane is an ingredient marketed to hair salons and consumers f
Autor:
Rolf W. Hartmann, Sandrine Marchais-Oberwinkler, Enrico Perspicace, Emanuele M. Gargano, Angelo Carotti
Publikováno v:
Bioorganicmedicinal chemistry letters. 26(1)
Four different classes of new 17β-hydroxysteroid dehydrogenase type 2 (17β-HSD2) inhibitors were synthesized, in order to lower the cytotoxicity exhibited by the lead compound A, via disrupting the linearity and the aromaticity of the biphenyl moie
Autor:
Emanuele M. Gargano, Enrico Perspicace, Angelo Carotti, Rolf W. Hartmann, Sandrine Marchais-Oberwinkler, Nina Hanke
Publikováno v:
European journal of medicinal chemistry. 87
17β-HSD2 is a promising new target for the treatment of osteoporosis. In this paper, a rational strategy to overcome the metabolic liability in the 2,5-thiophene amide class of 17β-HSD2 inhibitors is described, and the biological activity of the ne
Autor:
Nina Hanke, Emanuele M. Gargano, Enrico Perspicace, Rolf W. Hartmann, Sandrine Marchais-Oberwinkler, Angelo Carotti, Liliana Cozzoli
Publikováno v:
European journal of medicinal chemistry. 83
17β-Hydroxysteroid dehydrogenase type 2 (17β-HSD2) is responsible for the oxidation of the highly active estradiol (E2) and testosterone (T) into the less potent estrone (E1) and Δ4-androstene-3,17-dione (Δ4-AD), respectively. As 17β-HSD2 is pre